FDA Authorizes Covid-19 Pre-Exposure Prevention for Certain Individuals
GAINESVILLE – The Food and Drug Administration issued an emergency use authorization (EUA) for the first injectable monoclonal antibody medication for pre-exposure prevention of COVID-19 for certain adults and pediatric individuals (12 years and older). The pre-exposure therapy, Evusheld by Continue reading FDA Authorizes Covid-19 Pre-Exposure Prevention for Certain Individuals